Product image of Brivudina Doc (Brivudine) supplied by GNH India

Brivudina Doc

Active Ingredient:
Brivudine
Origin:
EU

Brivudina Doc (Brivudine)

Brivudine, the active ingredient in Brivudina Doc, is a nucleoside analog antiviral presented as a 125mg tablet for oral use. It is primarily used for the treatment of herpes infections, including herpes zoster and herpes simplex. GNH India supplies Brivudina Doc as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Brivudina Doc is designed to inhibit the replication of the virus, helping to reduce symptoms and speed up recovery. It is taken orally and is designed to target the underlying cause of the infection.

Manufacturer / TM Owner

Doc Generici S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Brivudina Doc is an antiviral medication used to treat herpes infections. It is effective in managing various conditions related to viral infections.

  • Herpes zoster (shingles): Reduces the severity and duration of symptoms associated with shingles.
  • Herpes simplex: Helps in managing outbreaks of herpes simplex infections.
  • Postherpetic neuralgia: May reduce the risk of developing chronic pain after shingles.

How It Works

  • Brivudine works by inhibiting viral DNA polymerase after intracellular phosphorylation to its triphosphate form. This action blocks viral DNA synthesis, preventing the virus from replicating and spreading within the body.

Side Effects

Brivudina Doc, like all medications, can cause side effects, although not everyone gets them. Common Side Effects:

  • Nausea
  • Headache
  • Fatigue
  • Diarrhea
  • Rash

Serious or Rare Side Effects

  • Severe allergic reactions
  • Liver toxicity
  • Bone marrow suppression
  • Neurological symptoms such as confusion or seizures

Precautions & Warnings

  • Brivudina Doc should be used with caution and under the supervision of a healthcare provider. Consult a healthcare provider before using this medication. Always store Brivudine in a cool, dry place away from direct sunlight. Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Brivudina Doc can interact with other medications, which may affect its efficacy or increase the risk of side effects. Major Interactions (Avoid):

  • Fluoropyrimidines: Can increase the risk of severe toxicity.
  • 5-Fluorouracil: Can lead to significant adverse reactions.

Moderate Interactions (Monitor Closely)

  • Immunosuppressants: May increase the risk of infections.
  • Antiviral medications: May require dosage adjustments.

Frequently Asked Questions

Brivudina Doc is used to treat herpes infections, including herpes zoster (shingles) and herpes simplex. It helps reduce the severity and duration of symptoms associated with these infections.

Brivudine works by inhibiting viral DNA polymerase after intracellular phosphorylation to its triphosphate form. This action blocks viral DNA synthesis, preventing the virus from replicating and spreading within the body.

The dosage of Brivudina Doc is determined by a healthcare provider based on the patient's condition and response to treatment. It is typically taken as one tablet once a day for seven days.

Pregnant or breastfeeding women should consult a healthcare provider before using Brivudina Doc. The safety of the medication during pregnancy and breastfeeding has not been fully established.

To order Brivudina Doc from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will reply with pricing, availability, shipping, and the import paperwork.

Brivudina Doc is specifically indicated for herpes infections and is known for its efficacy in reducing the severity and duration of symptoms. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider.

Brivudina Doc should be stored in a cool, dry place away from direct sunlight. Store below 25°C: keep in the original pack, protect from moisture.

Brivudina Doc is taken orally, typically as one tablet once a day for seven days. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider.

The most serious risks associated with Brivudina Doc include severe allergic reactions, liver toxicity, bone marrow suppression, and neurological symptoms such as confusion or seizures. Patients should seek medical attention if they experience any of these symptoms.

Patients with a known allergy to Brivudine or any of the excipients in Brivudina Doc should not use this medication. Additionally, patients with pre-existing liver or bone marrow conditions should consult a healthcare provider before using Brivudina Doc.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Brivudine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT